AU2022207648A9
(en )
2025-03-13
Isoindolinone compounds
CA3261302A1
(en )
2024-02-22
HETEROCYCLIC RBM39 MODULATORS
EP4241773A4
(en )
2024-10-16
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF LEUKEMIA WITH FLT3 INHIBITOR
AU2024246994A1
(en )
2025-11-13
Methods for reducing exogenous insulin use
HK40112940A
(zh )
2025-01-28
用於糖尿病的menin-mll相互作用的共价抑制剂
CA3263420A1
(en )
2024-02-01
FTO INHIBITORS
CA3265189A1
(en )
2024-02-22
MYELOPEROXIDASE INHIBITORS
EP4144734A4
(en )
2023-11-01
APPLICATION OF A HETEROCYCLIC COMPOUND
HK40103863A
(zh )
2024-07-12
异吲哚酮化合物
CA3289111A1
(en )
2024-10-31
Treatment of diabetes mellitus
CA3270489A1
(en )
2024-04-18
Compounds for use as medicaments
CA3260086A1
(en )
2025-10-30
Compounds as myt1 inhibitors
HK40107059A
(zh )
2024-10-04
用於树突棘生成的某些肌成束蛋白结合化合物
CA3280853A1
(en )
2024-08-29
Inhibitors of synaptogyrin-3 expression
HK40118483A
(zh )
2025-06-20
作为pi3ka抑制剂的杂环化合物
CA3279320A1
(en )
2024-07-18
Compounds for fgfrs inhibitors
HK40104116A
(zh )
2024-07-19
用於血红蛋白的确定的生物感测器
HK40098679A
(zh )
2024-04-05
用於单分子组织的基底
HK40123415A
(zh )
2025-10-17
能够活化sting的杂环化合物
CA3270840A1
(en )
2024-05-02
Heterocyclic compounds capable of activating sting
CA3266173A1
(en )
2024-05-02
HETEROCYCLIC COMPOUNDS CAPABLE OF ACTIVATING STING
HK40111748A
(zh )
2025-01-03
一种杂环化合物的应用
HK40092814A
(zh )
2023-12-29
治疗糖尿病的方法
CA3280714A1
(en )
2024-08-02
Substituted 1h-pyrazole-4-carboxamides as sarm1 inhibitors
AU2024298839A1
(en )
2025-01-30
Pharmaceutical composition containing heterocyclic compound